Variant report
Variant | esv3398990 |
---|---|
Chromosome Location | chr4:150263452-150265500 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs72724036 | chr4:150263494-150263495 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs551905797 | chr4:150263521-150263522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552011474 | chr4:150263566-150263567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566991968 | chr4:150263571-150263572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554239657 | chr4:150263576-150263577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572995005 | chr4:150263607-150263608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566172278 | chr4:150263631-150263632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540009562 | chr4:150263634-150263635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540269977 | chr4:150263722-150263723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148398908 | chr4:150263804-150263805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536641658 | chr4:150263852-150263853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556634133 | chr4:150263940-150263941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs75913639 | chr4:150263943-150263944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576438290 | chr4:150263990-150263991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373139261 | chr4:150263994-150263995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538757821 | chr4:150264048-150264049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558686708 | chr4:150264080-150264081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs182625067 | chr4:150264138-150264139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540858475 | chr4:150264190-150264191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201658110 | chr4:150264229-150264230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs70962758 | chr4:150264233-150264234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs543394529 | chr4:150264235-150264236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113693052 | chr4:150264237-150264238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs58911424 | chr4:150264284-150264285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs560847384 | chr4:150264350-150264351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs375166795 | chr4:150264378-150264379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574434744 | chr4:150264459-150264460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs200242791 | chr4:150264466-150264467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113844216 | chr4:150264474-150264475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs6854418 | chr4:150264498-150264499 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs558183839 | chr4:150264503-150264504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs576782669 | chr4:150264542-150264543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532204514 | chr4:150264543-150264544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192257369 | chr4:150264580-150264581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs199501590 | chr4:150264594-150264595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112691544 | chr4:150264625-150264626 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567914352 | chr4:150264660-150264661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs184320284 | chr4:150264792-150264793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs142482188 | chr4:150264825-150264826 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs548054766 | chr4:150264880-150264881 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs151323699 | chr4:150264899-150264900 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536952578 | chr4:150264920-150264921 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs6535674 | chr4:150264949-150264950 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs112401854 | chr4:150264986-150264987 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs377554369 | chr4:150265019-150265020 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140582308 | chr4:150265164-150265165 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs371063532 | chr4:150265192-150265193 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543445024 | chr4:150265213-150265214 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs374080512 | chr4:150265278-150265279 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs377529264 | chr4:150265326-150265327 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 21364760 | CNVD |
Epilepsy | 22083797 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:150263200-150263800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr4:150263800-150265400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr4:150264600-150265200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr4:150264600-150267000 | Enhancers | NHEK | skin |
5 | chr4:150264600-150267200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr4:150264800-150266200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr4:150264800-150266600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr4:150264800-150267200 | Enhancers | NHDF-Ad | bronchial |
9 | chr4:150265000-150266200 | Enhancers | NH-A | brain |
10 | chr4:150265000-150266800 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr4:150265200-150266000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
12 | chr4:150265400-150266200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |